John Hernandez

John Hernandez

Director/Miembro de la Junta en CARMAT SA .

Fortuna: 975 337 $ al 31/05/2026

59 años
Health Technology
Technology Services
Consumer Services

Perfil

John B. Hernandez currently works at Carmat SA, as Independent Director from 2021 and Google LLC, as Head-Clinical Research & Health Economics from 2018.
Dr. Hernandez also formerly worked at IQVIA Holdings, Inc., as Director-e-Clinical from 2000 to 2001, Abbott Laboratories, as VP-Global Health Economics & Outcomes Research from 2010 to 2016, Boston Scientific Corp., as VP-Health Economics & Clinical Research from 2001 to 2010, Abbott Vascular, Inc., as Vice President-Medico-Economic Research from 2010 to 2016, and Verily Life Sciences LLC, as Head-Medico-Economic Affairs & Market Access from 2016 to 2018.
Dr. Hernandez received his undergraduate degree from The University of North Carolina at Chapel Hill and graduate degree and doctorate degree from Frederick S.
Pardee RAND Graduate School.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
20/11/2025 5.118 ( 0 % ) 975 337 $ 31/05/2026

Cargos activos de John Hernandez

EmpresasCargoInicio
CARMAT SA Director/Miembro de la Junta 07/05/2021
RESMED, INC. Director/Miembro de la Junta 18/11/2021
Corporate Officer/Principal 01/09/2018

Antiguos cargos conocidos de John Hernandez.

EmpresasCargoFin
Corporate Officer/Principal 01/09/2018
ABBOTT LABORATORIES Corporate Officer/Principal 01/03/2016
Corporate Officer/Principal 01/01/2016
BOSTON SCIENTIFIC CORPORATION Corporate Officer/Principal 01/01/2010
IQVIA HOLDINGS INC. Corporate Officer/Principal 01/01/2001
Ver el detalle de la experiencia de John Hernandez.

Formación de John Hernandez.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

72

Relaciones de 1er grado

10

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas10

Health Technology

Health Technology

Health Technology

Technology Services

Consumer Services

Consumer Services

Health Technology

Health Technology

Technology Services

Health Technology

-40%: Ampliación de plazo extraordinaria
d
:
:
APROVECHAR LA PROMOCIÓN